Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study.
about
Multimorbidity in rheumatic conditionsCardiovascular Comorbidity in Inflammatory Rheumatological Conditions.Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study.Efficacy and safety of non-pharmacological and non-biological pharmacological treatment: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis.Nurses' Role in Cardiovascular Risk Assessment and Management in People with Inflammatory Arthritis: A European Perspective.Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders.Sex and Cardiovascular Involvement in Inflammatory Joint Diseases.Radiographic progression is associated with increased cardiovascular risk in patients with axial spondyloarthritis.Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study.Cardiovascular risk profiles in a hospital-based population of patients with psoriatic arthritis and ankylosing spondylitis: a cross-sectional study.Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis?Epidemiology of axial spondyloarthritis: an update.The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis.The association between ankylosing spondylitis and the risk of any, hip, or vertebral fracture: A meta-analysis.Evaluation of the comorbidity burden in patients with ankylosing spondylitis using a large US administrative claims data set.Effects of colchicine on risk of cardiovascular events and mortality among patients with gout: the effect of index date selection?Evaluation of the comorbidity burden in patients with ankylosing spondylitis treated with tumour necrosis factor inhibitors using a large administrative claims data set.Risk of myocardial infarction with use of selected non-steroidal anti-inflammatory drugs in patients with spondyloarthritis and osteoarthritis
P2860
Q28070338-04C4330E-A1D5-4C16-9192-B0BFDF11A09CQ33582869-B295558B-9D7C-4E7A-992F-3640F0642729Q33706485-E0B8AC14-1859-4F9D-BA89-F12CAC6E30FBQ37612248-33F0C329-7976-4B38-AB4A-7D2D2AD9C27BQ38628320-261F2C78-6E58-4B60-9722-64FED0604FEEQ38738136-4F22ED94-31F9-4E1C-A6D3-8CCA8814CA1EQ40065441-D0B783F0-0C05-4E1B-87FC-3216D84107E3Q40324538-6A75BE59-BD02-44CE-87B9-A97356FAAFB2Q40405924-7A25C1CF-5170-440B-8152-33DA41ED0ADAQ40455996-68D68426-2685-45EF-BFB0-5FAA8E6E7843Q40709084-2CA39FBF-3109-4FBA-89F6-FEDD795D241AQ47331733-E587F9F9-626D-4695-8340-169C221C0DE8Q47818153-EF0B435C-5846-4074-B3F0-ADA2C3AFB475Q49488203-F23C790A-51C3-4620-B23A-335FB481D87FQ52594754-41E75D12-CC03-48B5-9E63-6999B57F9C61Q53197159-4C5DCBD5-1EF1-40A6-974A-832FA0C8469FQ55382874-12CD5630-518A-4CA6-8523-B723B247BDC0Q57751622-F961C023-DA81-49B8-852E-A5E220E6F663
P2860
Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Ankylosing spondylitis and ris ...... population-based cohort study.
@en
Ankylosing spondylitis and ris ...... population-based cohort study.
@nl
type
label
Ankylosing spondylitis and ris ...... population-based cohort study.
@en
Ankylosing spondylitis and ris ...... population-based cohort study.
@nl
prefLabel
Ankylosing spondylitis and ris ...... population-based cohort study.
@en
Ankylosing spondylitis and ris ...... population-based cohort study.
@nl
P2093
P2860
P1476
Ankylosing spondylitis and ris ...... population-based cohort study.
@en
P2093
Annelies Boonen
Astrid van Tubergen
Ivette Essers
Marie L De Bruin
Marloes T Bazelier
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-206147
P407
P577
2014-10-31T00:00:00Z